ProfileGDS4177 / 210205_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 57% 58% 63% 58% 54% 57% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated46.5657
GSM603099KU-812 non-treated46.758
GSM603098KCL-22 Imatinib-treated62.5463
GSM603097KCL-22 non-treated47.7358
GSM603102JURL-MK1 Imatinib-treated40.0154
GSM603101JURL-MK1 non-treated43.8857